Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Puma Biotechnology Inc    PBYI   US74587V1070

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Puma Biotechnology : PBYI) Drops 5% on August 21

08/22/2014 | 11:23am US/Eastern

Puma Biotechnology Inc (PBYI) was one of the Russell 2000's biggest losers for August 21 as the stock slid 5% to $237.41, a loss of $12.5 per share. Starting at an opening price of $250.12 a share, the stock traded between $234.62 and $251.88 over the course of the trading day. Volume was 417,667 shares over 4,418 trades. The company has a total float of 30,117,819.

The losses send Puma Biotechnology Inc down to a market cap of $7,150,271,409

For a full analysis of Puma Biotechnology Inc, check out Equities.com's E.V.A. report.

One of the most effective tools for tracking the market for small-cap stocks is the Russell 2000, the nation's leading small-cap index created by industry stalwart Russell Investments. Unlike the well-known Dow Jones Industrial Average (DJIA) and S&P 500, Russell's indices eschew committee selection in favor of a more objective, rules-based system for selecting index membership.

The broad-based Russell 3000, which is meant to cover the stock market as a whole, is simply the 3,000 companies with the largest market cap in the United States. The Russell 2000 is then just the bottom 2,000 companies of that index, offering a look at those small-cap companies with smaller market caps. It makes for an unbiased overview of the small-cap stocks that can help any investor get a better sense of what the market is doing and where it might be headed.

For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.

All data provided by QuoteMedia and was accurate as of 4.30PM.

Copyright 2014.Equities.com. All rights reserved.

React to this article
Latest news on PUMA BIOTECHNOLOGY INC
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
1d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
3d ago PUMA BIOTECHNOLOGY : Releases Trial Data at 2014 CTRC-AACR San Antonio Breast Ca..
12/12 PUMA BIOTECHNOLOGY : Other Events, Financial Statements and Exhibits (form 8-K)
12/12 PUMA BIOTECHNOLOGY : Announces Positive Interim PB272 (Neratinib) Phase II Data ..
12/11 ISIS PHARMACEUTICALS : IWM, QAT: Big ETF Inflows
12/10 PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP La..
12/09 PUMA BIOTECHNOLOGY : INVESTOR ALERT: Investigation of Puma Biotechnology, Inc. A..
12/08 PUMA BIOTECHNOLOGY : NYSE:PBYI) Investor Alert: Investigation over Potential Wro..
12/05 PUMA BIOTECHNOLOGY : Extends Timeline for Filing New Drug Application
Advertisement
Chart
Duration : Period :
Puma Biotechnology Inc Technical Analysis Chart | PBYI | US74587V1070 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF